Wikipedia:Articles for deletion/Cergutuzumab amunaleukin


 * The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review).  No further edits should be made to this page.

The result was speedily deleted by Ben MacDui per CSD G6 and CSD G7. (non-admin closure) • Gene93k (talk) 02:08, 13 January 2018 (UTC)

Cergutuzumab amunaleukin

 * – ( View AfD View log  Stats )

This drug is only in phase I clinical trials. Rule of thumb for experimental drug notability requires phase II trials. Natureium (talk) 20:02, 8 January 2018 (UTC)


 * Userfy per nom. --Tyranitar Man (talk) 20:34, 8 January 2018 (UTC)
 * Note: This discussion has been included in the list of Medicine-related deletion discussions. Baby miss  fortune 02:55, 9 January 2018 (UTC)


 * Boldly moved to User:Tyranitar_Man/Cergutuzumab_amunaleukin. See Articles for deletion/Afasevikumab for rationale. Tigraan Click here to contact me 17:03, 9 January 2018 (UTC)


 * The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.